The American Journal of Gastroenterology
IF
10.17
Papers
62498
Papers 10000
1 page of 1,000 pages (10k results)
Newest
#1Vanessa Yu (BIDMC: Beth Israel Deaconess Medical Center)
#2Sarah BallouH-Index: 14
Last. Anthony LemboH-Index: 56
view all 9 authors...
INTRODUCTION Patients with disorders of gut-brain interaction (DGBIs) are high users of health care. Past studies exploring predictors of utilization have lacked patient-level clinical data. The aim of the current study is to identify demographic, clinical, and psychological predictors of health care utilization in patients with irritable bowel syndrome (IBS), functional constipation (FC), and functional diarrhea (FDr). METHODS Consecutive new patients diagnosed with IBS, FC, and FDr (using Rome...
Source
#1Takahiro Inoue (Osaka University)H-Index: 12
#1Takahiro InoueH-Index: 24
Last. Ryu IshiharaH-Index: 33
view all 6 authors...
Source
Clostridioides difficile infection occurs when the bacterium produces toxin that causes diarrhea and inflammation of the colon. These guidelines indicate the preferred approach to the management of adults with C. difficile infection and represent the official practice recommendations of the American College of Gastroenterology. The scientific evidence for these guidelines was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation process. In instances where the ev...
Source
INTRODUCTION: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 virus, is a predominantly respiratory tract infection with the capacity to affect multiple organ systems. Abnormal liver tests, mainly transaminase elevations, have been reported in hospitalized patients. We describe a syndrome of cholangiopathy in patients recovering from severe COVID-19 characterized by marked elevation in serum alkaline phosphatase (ALP) accompanied by evidence of bile...
Source
#1Darren M. Brenner (NU: Northwestern University)H-Index: 15
#2Brian E. Lacy (Mayo Clinic)H-Index: 39
Chronic abdominal pain is a common gastrointestinal (GI) symptom that characterizes many functional GI disorders/disorders of gut-brain interaction, including irritable bowel syndrome, functional dyspepsia, and centrally mediated abdominal pain syndrome. The symptoms of abdominal pain in these highly prevalent disorders are often treated with antispasmodic agents. Antispasmodic treatment includes a broad range of therapeutic classes with different mechanisms of action, including anticholinergic/...
Source
#1Calvin Jianyi Koh (NUS: National University of Singapore)H-Index: 4
view all 3 authors...
Source
#1Wojciech Marlicz (Pomeranian Medical University)H-Index: 19
#2Anastasios Koulaouzidis (Pomeranian Medical University)H-Index: 27
Last. George Koulaouzidis (Pomeranian Medical University)
view all 3 authors...
Source
#1Binu John (Veterans Health Administration)H-Index: 16
#2Nidah S. Khakoo (JMH: Jackson Memorial Hospital)
Last. Tamar H. TaddeiH-Index: 19
view all 11 authors...
INTRODUCTION Patients with cirrhosis and men have been under-represented in most studies examining the clinical benefit of response to ursodeoxycholic acid (UDCA) in primary biliary cholangitis (PBC). The aim of this study was to study the association of UDCA response and liver-related death or transplantation, hepatic decompensation, and hepatocellular carcinoma (HCC) in patients with PBC cirrhosis. METHODS We conducted a retrospective cohort study of veterans, predominantly men, with PBC and c...
Source
#1Kenta Watanabe (Akita University)H-Index: 1
#2Yosuke ShimodairaH-Index: 4
Last. Katsunori IijimaH-Index: 25
view all 7 authors...
INTRODUCTION Proton pump inhibitors (PPIs) are associated with the onset of Clostridioides difficile infection (CDI). Although a new potassium-competitive acid blocker, vonoprazan, consistently shows a more potent acid inhibitory effect in comparison to PPIs, the risk of CDI in vonoprazan-treated patients relative to those treated with PPIs is unknown. In this retrospective case-control study, using a nationwide hospital-based administrative database in Japan, we investigated the association of ...
Source
#1Max Schmulson (UNAM: National Autonomous University of Mexico)H-Index: 23
ABSTRACT This Editorial analyzes the paper by Schnadower et al on the secondary analysis of 2 randomized placebo-controlled trials evaluating the efficacy of Lactobacillus rhamnosus GG, and a combination of L. rhamnosus R0011 and L. helveticus R0052, showing that moderate-to-severe gastroenteritis symptoms as primary endpoint, did not differ between probiotics or placebo. The data is important because probiotics are commonly used and prescribed in clinical practice, many times without strong evi...
Source
12345678910
Top fields of study
Radiology
Surgery
Pathology
Diabetes mellitus
General surgery
Medicine
Gastroenterology